key: cord-0007390-sifwtqa4 authors: Mattila, Leena title: Clinical Features and Duration of Traveler's Diarrhea in Relation to Its Etiology date: 1994-10-03 journal: Clin Infect Dis DOI: 10.1093/clinids/19.4.728 sha: db54b1a5c223be36b7381064f20d690920e83ddc doc_id: 7390 cord_uid: sifwtqa4 Clinical features of traveler's diarrhea (TD) were studied among 126 adult Finnish tourists who developed this illness during or shortly after a visit to Morocco. Enteric pathogens were identified in 76 (60%) of cases, whereas the etiology remained unidentified in 50 cases (40%). Patients with an identified pathogen did not differ from those with TD of unknown etiology in terms of the time of onset of illness or the median frequency of unformed stools in the first 24 hours. In contrast, the median frequency of unformed stools between 24 and 48 hours (i.e., on the second day) was 1.0 among patients with no pathogen and 2.0 among those with enteric pathogens identified (P < .001). A similar difference was evident on the third day (1.0 vs. 2.5). Moreover, a lower proportion of patients with no pathogen identified had watery stools (28% vs. 55%). The durations of diarrhea and concomitant symptoms were significantly shorter and the recovery from TD was significantly quicker among the patients without an identified pathogen. Patients with one or more invasive pathogens had disease that was clearly more severe than that of patients with no pathogen identified; the difference in severity of disease was less marked for patients with invasive vs. noninvasive pathogens. Individuals with diarrhea due to Campylobacter species tended to have the most severe disease, whereas diarrhea caused by enterotoxigenic Escherichia coli seemed milder than that caused by other agents. Unfortunately, the clinician has only a limited opportunity to predict the etiology of TD and thus to assess the need for antimicrobial therapy at the onset of disease. From the National Public Health Institute, Helsinki, Finland Clinical features of traveler's diarrhea (TD) were studied among 126 adult Finnish tourists who developed this illness during or shortly after a visit to Morocco. Enteric pathogens were identified in 76 (60%) of cases, whereas the etiology remained unidentified in 50 cases (40%). Patients with an identified pathogen did not differ from those with TD of unknown etiology in terms of the time of onset of illness or the median frequency of unformed stools in the first 24 hours. In contrast, the median frequency of unformed stools between 24 and 48 hours (Le., on the second day) was 1.0 among patients with no pathogen and 2.0 among those with enteric pathogens identified (P < .001). A similar difference was evident on the third day (1.0 vs. 2.5). Moreover, a lower proportion of patients with no pathogen identified had watery stools (28% vs. 55%). The durations ofdiarrhea and concomitant symptoms were significantly shorter and the recovery from TD was significantly quicker among the patients without an identified pathogen. Patients with one or more invasive pathogens had disease that was clearly more severe than that of patients with no pathogen identified; the difference in severity of disease was less marked for patients with invasive vs. noninvasive pathogens. Individuals with diarrhea due to Campylobacter species tended to have the most severe disease, whereas diarrhea caused by enterotoxigenic Escherichia coli seemed milder than that caused by other agents. Unfortunately, the clinician has only a limited opportunity to predict the etiology ofTD and thus to assess the need for antimicrobial therapy at the onset of disease. Traveler's diarrhea (TD) is a frequent medical problem for tourists in developing countries [1] [2] [3] and is costly to both the traveler and the host country. High-risk areas for TD include Africa, Latin America, and Asia [4] . Various infectious agents may cause TD, but bacteria are responsible for --80% ofcases [5, 6] . Although techniques for identifying the bacteria, viruses, and parasites responsible for TD have improved, the etiology remains unknown in 15%-55% (and, in rare instances, up to 75%) of cases [7] [8] [9] [10] [11] [12] , The etiology of TD varies both geographically and seasonally [13] [14] [15] [16] . Investigators have long attempted to correlate the symptoms and signs of diarrheal diseases with a specific etiology, usually with little success [17] [18] [19] [20] [21] [22] [23] . Although adequate comparisons of patients with TD of different etiologies generally have not been possible, a few trends have been noted. Campylobacter enteritis has been described as intense diarrhea with abdominal pain and fever in more than 50% of cases. Salmonellosis has been associated with classic enteric fever or severe diarrhea with abdominal pain, whereas shigella enteritis typically has an abrupt onset with bloody or watery stools, abdominal pain, and fever. Enteritis associated with enterotoxigenic Escherichia coli (ETEC) varies considerably but is usually of relatively short duration. Little is known about diarrhea associated with Aeromonas species. A recent study ofTD among Finnish travelers to Morocco [24] offered an opportunity to compare the clinical presentation of TD cases according to etiology: no identified pathogen, invasive pathogen(s), or noninvasive pathogen(s). The population studied consisted of 126 individuals from a group of978 Finnish tourists participating in two packaged tours to Agadir, Morocco [15, 24] . Of the 254 travelers who developed TD during or within 1 week after the tours, 71 were excluded from the study because they had received norfloxacin in a randomized trial of treatment [25] . (The disease was initially as severe in this group as it was in the group that was included in the study.) Follow-up data were available for 126 of the remaining 183 patients with TD. Of these 126 persons, 39 had received B-subunit/whole-cell cholera vaccine. Although that vaccine reduced the risk ofTD caused by ETEC alone or in combination with other pathogens [24] , it had no effect on the clinical features of the cases that did develop (author's unpublished observation). Thus these patients were not excluded from the study. The tours took place in January and February 1989 and in October and November 1989 and lasted for 1 or 2 weeks. An office for the study's personnel (two Finnish physicians, a nurse, and laboratory staff [15] ) was established at a local hotel in Agadir. Diarrhea was defined as the passage of four or more unformed stools in a period of 24 hours or of three or more unformed stools in a period of 8 hours. In addition to diarrhea, at least one of the following signs or symptoms had to be present for inclusion of a patient in the study: abdominal pain or cramps, nausea, vomiting, or fever [26] . Patients were instructed to contact the study personnel as soon as symptoms developed. One of the study's physicians interviewed and examined the patient within a few hours. Each patient kept a diary during the illness and met with a physician or nurse at least twice before recovery. Individuals who developed gastrointestinal symptoms within a week after returning home were asked to submit a stool specimen and to fill in a questionnaire. If the symptoms fit the case definition, the patient was included in the study. (Twentytwo of the 126 patients were enrolled in this manner.) Self-medication was not allowed. Five patients received 22 (17) I I 3 I I I I I 3 I I I 2 2 I I metoclopramide, six patients received loperamide, and three patients received metamizole during the course of diarrhea; these medications were given by the physician to alleviate the symptoms of TD during the long flight home or a long day trip. In no other case was the use of a drug for TD reported. A stool sample collected at the diagnosis ofTD was examined macroscopically for mucus, blood, and/or a watery or loose appearance and was cultured by standard methods for Salmonella, Shigella, Campylobacter, Yersinia, Aeromonas, and Plesiomonas species [27] . Standard culture methods were used for detecting enteroviruses or adenoviruses [28] in the first 43 samples, which were collected during the first trip (January and February 1989). As culture of specimens did not yield viruses with these standard methods, the latex agglutination test was used for specimens collected during the second trip (October and November 1989). Final identification of bacterial pathogens took place in the National Public Health Institute in Helsinki. ETEC was identified by ELISAs for heat-labile and heat-stable enterotoxins, enteropathogenic E. coli (EPEC) serogroups and enterohemorrhagic E. coli (EHEC) serogroup 0157 by serotyping, and enteroinvasive E. coli (EIEC) by tissue culture [29] [30] [31] [32] [33] . In statistical analyses, proportional data were compared with the x 2 test. The t test or the Mann-Whitney U test was used for the comparison of continuous variables. For multiple pairwise comparison of quantitative variables, analysis of variance was followed by Scheffe's method. For the comparison of variables with highly skewed distributions, logarithmic transformation or nonparametric tests (Kruskal-Wallis analysis of variance or the Kruskal-Wallis test adjusted for multiple comparisons) were employed. The independent dis- * Values refer to overall comparison between the three subgroups. t As the appearance of stools was roughly classified. only an overall comparison between the SUbgroups was considered meaningful. criminatory power of each risk factor was assessed by stepwise discriminant analysis. The relation between the number of unformed stools and the duration of diarrhea was expressed as the Spearman-rank correlation. The Kaplan-Meier life-table method was used for the comparison of cumulative proportions of patients recovering from TD. On the basis of microbiological results, the 126 patients with TD were divided into two groups: those with an identified enteropathogen (76 patients, 60%) and those without an identified pathogen (50 patients, 40%). The pathogens isolated are listed in table 1. The group with identified pathogens was further divided into two SUbgroups: those with one or more invasive pathogens (45 patients) and those with one or more noninvasive pathogens (31 patients). (The isolation of any invasive pathogen qualified a patient for the former category.) Shigella species, Salmonella enterica, Campylobacter species, and EIEC were considered invasive pathogens, whereas ETEC, EPEC, EHEC, Aeromonas species, and rotavirus were considered noninvasive [34] . ETEC, the most common single pathogen, was identified alone in 17 (31 %) of 54 cases. It was followed in frequency by S. enterica (22%) and Campylobacter species (22%). ETEC and S. enterica were also the ,most common isolates in the 22 cases in which multiple pathogens were identified. Rotavirus was the only viral agent detected; it was found alone in four cases and together with S. enterica in one case. The mean age ofthe 126 patients was 44.0 years; 86 (68%) were female (table 2). Eighty-eight patients (70%) spent 1 week in Morocco, and the rest spent 2 weeks. No differences in age, sex, or duration of stay in Morocco were documented among the three groups (no pathogen, invasive pathogen, and noninvasive pathogen). The median time of onset of TD was 6.0 days after the (table 3) . The frequency ofunformed stools on the first day after onset of diarrhea was also the same for all groups. However, the frequency differed significantly on the second and third days, when the median numbers ofloose stools were 1.0 and 1.0, respectively (mean numbers, 0.8 and 1.0, respectively) for patients without identified pathogens and were 2.0 and 2.5, respectively (mean numbers, 3.4 and 3.2, respectively) for those with identified pathogens. Watery stools were less common in the latter group than in the former (28% vs. 55%). Bloody diarrhea was documented in only two cases, both of which had an identified etiology (rotavirus in one case and Campy/obacter jejuni plus S. enterica in the other). Abdominal pain was reported by 98 patients. The type and severity of this pain did not differ in the groups with and without identified pathogens (data not shown). However, abdominal pain tended to occur in a higher proportion of patients with invasive pathogens than of those with noninvasive pathogens (table 3) . Fever was documented in 18% of patients with no identified pathogen and in 37% ofthose with identified pathogens (P < .0 I); it was most common among patients with invasive pathogens (42%). The frequencies of other concomitant symptoms were similar in the various groups. The durations of diarrhea and concomitant symptoms (nausea, abdominal pain, and fever) were significantly shorter among patients without an identified pathogen than among those with identified pathogens (table 3) . In this study, the durations ofdiarrhea and ofconcomitant symptoms of TD (nausea, abdominal pain, and fever) were significantly shorter among cases without than among those with an identified etiology. The clinical features of TD on the first day of illness were quite similar in these two groups, Recovery from TD-i.e., the resolution of all symptoms -took significantly longer in cases without an identified etiology (P < .001, figure 1) . Specifically, diarrhea lasted for <2 days in 50% of cases with no identified pathogen but persisted for at least 4 days in 50% of cases with an identified pathogen. The groups with invasive and noninvasive pathogens did not differ statistically in terms of recovery time. The number of unformed stools during the first 24 hours of TD correlated with the ultimate duration of diarrhea (r = 0.3015; P < .01) but not with etiology. In an evaluation of the clinical features of the etiologic groups, a stepwise discriminant analysis was performed; the presence and severity of abdominal pain, nausea, and fever and the frequency of unformed stools were included in the model. None of these parameters was associated with etiology during the first 24 hours of illness; however, the number of unformed stools on the second day proved a significant independent discriminator among the etiologic groups. Discriminant analysis based on this variable correctly classified 64% of all cases: 92% of those with no pathogen identified and 48% of those with one or more pathogens identified. The clinical profile of TO caused by single specific pathogens was evaluated (table 4) . ETEC was isolated in 17 of these cases, and Campy/obacter species and S. enterica were identified in 12 cases each. Despite these relatively small numbers, some clinical features were significantly associated with each pathogen. On the first day of illness, the clinical features in all groups were quite similar. In cases in which ETEC was identified, diarrhea proved to be quite mild, to be associated with mucous stools in many cases, and to be associated with nausea or vomiting, fever, and other systemic symptoms in few cases. Campy/obacter species tended to cause the most severe disease, with a large number of unformed stools on the first, the second, and especially the third day and a frequent association with abdominal pain, nausea or vomiting, and fever. S. enterica was associated with moderately severe disease. In seven cases, diarrhea was associated with Aeromonas species. These cases were quite severe, with a large number of unformed stools and nausea documented on the first day. Four cases of diarrhea were associated with rotavirus. The clinical features of these cases were not distinguishable from those of cases with a bacterial etiology. All four of the patients involved had nausea and abdominal pain, and three of the four had fever. Three patients had watery stools, and one patient had bloody stools. :I: As the appearance of stools was roughly classified, only an overall comparison between the subgroups was considered meaningful. but the number of unformed stools was significantly smaller on the second and third days in the group without an identified etiology. As in earlier studies [19, 35, 36] , disease was less severe in cases without an identified etiology than in those with at least one identified pathogen. The differences between cases due to invasive pathogens and those due to [21) . In their analysis, nausea and abdominal cramps were equally common in all etiologic groups, and patients with a mild clinical presentation-regardless ofetiology-recovered sooner than those who initially were moderately or severely ill. In our study, --33% of patients without an identified pathogen and --43% of those with an identified pathogen reported nausea. Nausea was common among cases associated with Aeromonas species (71 %) or Campylobaeter species (58%) but was uncommon among cases associated with S. enteriea (8%) or ETEC (18%). Moreover, abdominal pain was frequent both with (76%) and without (80%) an identified etiology. Kollaritsch studied the clinical features of enteritis among 1,455 Austrian tourists visiting various developing countries between 1986 and 1988 [37) . In this questionnaire-based study, 57% ofpatients had abdominal cramps, 13% had fever, and 30% had nausea or vomiting. The onset of TD came around the ninth day of travel; in contrast, the median time to onset in our study was 6 days. During the acute illness of the patients in our study, the frequency of stools was about four per day, and the mean duration of diarrhea ± SD was 3.6 ± 2.7 days. Fever was rather uncommon; it was more common among cases with than among those without an identified pathogen (37% vs. 18%) and was most common among cases due to an invasive pathogen (42%). What causes cases of TD in which no pathogen is identified? In the present study, the stool specimen for culture was taken after the passage of three or four unformed stools, and the culture methods used were of high quality. Thus major enteropathogens would very likely have been detected. However, the use of methods for the detection of some other potential pathogens (e.g., astroviruses, coronavirus, Norwalk virus, Hafnia alvei, Campylobaeter upsaliensis, Campylobaeter butzleri, Cryptosporidium species, and enteroadhesive E. coli) might have revealed the etiology of a few more cases [38] [39] [40] [41] [42] [43] [44] [45] [46] . Processing of more than one stool specimen per patient might also have been fruitful. It remains unclear whether TD can be due to changes in the normal flora without the involvement of enteric pathogens. In conclusion, the first day ofTD was fairly similar regardless ofetiology, but recovery was significantly quicker among patients without an identified pathogen. In other words, a lower frequency of unformed stools after the first 24 hours distinguished the group with unknown etiology from that with an identified etiology. Fifty percent of patients with fewer than three stools on the second day had no identifiable pathogen. Unfortunately, the clinician has only a limited opportunity to predict the etiology ofTD and thus to assess the need for antimicrobial therapy in individual patients at the onset of disease. Epidemiology of diarrhea in travelers Trips to the South-a health hazard. Morbidity of Finnish travellers Epidemiologic studies of travelers' diarrhea. severe gastrointestinal infections, and cholera Emporiatric enteritis: lessons learned from U.S. students in Mexico Prevention and treatment of traveler's diarrhea Furazolidone versus ampicillin in the treatment of travelers' diarrhea Echeverria P. Etiology ofdiarrhea among travelers and foreign residents in Nepal Travelers' diarrhea in West Africa and Mexico: fecal transport systems and liquid bismuth subsalicylate for self-therapy Bitsura JM. Treatment of traveler's diarrhea with sulfamethoxazole and trimethoprim and loperamide Evaluation of diarrhea in the returning traveler Treatment and prevention of travellers' diarrhoea Etiology and epidemiology of travelers' diarrhea in Asia Pathogens that cause travelers' diarrhea in Latin America and Africa Seasonal variation in etiology of travelers' diarrhea Travellers' diarrhoea. Which antimicrobial? Accuracy of diagnosis of bacterial diarrheal disease by clinical features Epidemiologic and clinical features of patients infected with Shigella who attended a diarrheal disease hospital in Bangladesh Bicozamycin, a poorly absorbable antibiotic. effectively treats travelers' diarrhea A comparison of the clinico-pathological features with stool pathogens in patients hospitalised with the symptom of diarrhoea Clinical presentation as a guide to therapy for travelers' diarrhea Acute diarrhoea in adults: aetiology, clinical appearance and therapeutic aspects Intestinal manifestations of invasive diarrheas and their diagnosis Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico Manual of clinical microbiology Clinical virology manual Rapid GM I-enzyme-linked immunosorbent assay with visual reading for identification of Escherichia coli heat-labile enterotoxin Monoclonal antibodies against Escherichia coli heat-stabile toxin (STa) and their use in a diagnostic ST ganglioside GM I-enzyme-linked immunosorbent assay Haemolytic uraemic syndromes in the British Isles, 1985-8: association with Verocyto-Mattila CID Part 2: Microbiological aspects Comparison ofan HEp-2 tissue culture test with the Sereny test for detection of enteroinvasiveness in Shigella spp. and Escherichia co/i Principles and syndromes of enteric infection Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone Five versus three days ofofloxacin therapy for traveler's diarrhea: a placebo-controlled study Traveller's diarrhea among Austrian tourists to warm climate countries: II. Clinical features Coronavirus propagated from patient with nonbacterial gastroenteritis Travelers' diarrhea in Panamanian tourists in Mexico Cryptosporidiosis associated with traveling and giardiasis Occurrence of Norwalk virus infections among adults in Mexico Is 'Campy/obacter upsaliensis' an unrecognised cause of human diarrhoea? Astroviruses as a cause of gastroenteritis in children Hafnia alvei. a probable cause of diarrhea in humans Campy/obacter butz-/eri sp. nov. isolated from humans and animals with diarrheal illness Colonization by enteroaggregative Escherichia coli in travelers with and without diarrhea The author thanks Professors P. Helena Makela and Heikki Peltola for critical reading of the manuscript and Anja Siitonen, Ph.D., for valuable help in preparing the manuscript.